Otonomy to Present at the Needham Virtual Healthcare Conference
April 06 2021 - 7:30AM
Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company
dedicated to the development of innovative therapeutics for
neurotology, today announced its participation in the 20th Annual
Needham Virtual Healthcare Conference. David A. Weber, Ph.D.,
president and CEO of Otonomy, will present a company overview on
Tuesday, April 13, 2021 at 4:30 p.m. ET (1:30 p.m. PT).
A live audio webcast of the presentation will be available
through the Events page of the company's website (www.otonomy.com).
An archived webcast of the presentation will also be available on
the same web page shortly after the live event.
About OtonomyOtonomy is a biopharmaceutical
company dedicated to the development of innovative therapeutics for
neurotology. The company pioneered the application of drug delivery
technology to the ear in order to develop products that achieve
sustained drug exposure from a single local administration. This
approach is covered by a broad patent estate and is being utilized
to develop a pipeline of products addressing important unmet
medical needs with a focus on hearing loss and tinnitus. For
additional information please visit www.otonomy.com.
Contacts:
Media InquiriesSpectrum ScienceChloé-Anne RamseyVice
President404.865.3601cramsey@spectrumscience.com
Investor InquiriesWestwicke ICRRobert H. UhlManaging
Director858.356.5932robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jul 2023 to Jul 2024